LVM CAPITAL MANAGEMENT LTD/MI - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
LVM CAPITAL MANAGEMENT LTD/MI ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$252
+25.4%
23,0000.0%0.03%
+21.4%
Q1 2023$201
+219.0%
23,000
+130.0%
0.03%
+211.1%
Q4 2022$63
-99.8%
10,0000.0%0.01%
+80.0%
Q3 2022$35,000
+16.7%
10,0000.0%0.01%
+25.0%
Q2 2022$30,000
-45.5%
10,000
-33.3%
0.00%
-50.0%
Q3 2021$55,000
-15.4%
15,0000.0%0.01%
-20.0%
Q2 2021$65,000
-4.4%
15,0000.0%0.01%
-9.1%
Q1 2021$68,000
-26.1%
15,000
-6.2%
0.01%
-31.2%
Q4 2020$92,000
-20.7%
16,0000.0%0.02%
-27.3%
Q3 2020$116,000
+107.1%
16,0000.0%0.02%
+100.0%
Q2 2020$56,000
+133.3%
16,0000.0%0.01%
+83.3%
Q1 2020$24,000
-22.6%
16,0000.0%0.01%0.0%
Q4 2019$31,000
-62.2%
16,0000.0%0.01%
-64.7%
Q3 2019$82,000
-28.7%
16,0000.0%0.02%
-34.6%
Q2 2019$115,000
-45.8%
16,0000.0%0.03%
-46.9%
Q1 2019$212,000
+3.4%
16,000
-38.5%
0.05%
-9.3%
Q4 2018$205,000
-28.8%
26,0000.0%0.05%
-18.2%
Q3 2018$288,000
-17.5%
26,0000.0%0.07%
-21.4%
Q2 2018$349,000
+27.8%
26,000
+23.8%
0.08%
+33.3%
Q1 2018$273,000
+41.5%
21,0000.0%0.06%
+43.2%
Q4 2017$193,000
+14.2%
21,0000.0%0.04%
+10.0%
Q3 2017$169,000
+47.0%
21,000
+5.0%
0.04%
+37.9%
Q2 2017$115,000
+167.4%
20,000
+100.0%
0.03%
+163.6%
Q1 2017$43,00010,0000.01%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders